Butterfly Network (BFLY) Total Non-Current Liabilities (2020 - 2026)
Butterfly Network (BFLY) reported Total Non-Current Liabilities of $86.2 million for Q1 2026, up 23.48% on a YoY basis from $69.8 million in Q1 2025, and down 6.51% sequentially from $92.2 million in Q4 2025.
Butterfly Network (BFLY) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
Butterfly Network (BFLY) has 7 years of Total Non-Current Liabilities data on file, last reported at $86.2 million in Q1 2026.
- For the quarter ending Q1 2026, Total Non-Current Liabilities rose 23.48% year-over-year to $86.2 million; the trailing twelve-month figure through Mar 2026 stood at $86.2 million (up 23.48% YoY), and the FY2025 full-year result was $92.2 million, up 17.32% from the prior year.
- Total Non-Current Liabilities retreated to $86.2 million in Q1 2026, from $92.2 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $121.9 million in Q1 2022 to a low of $69.8 million in Q1 2025.
- A 5-year average of $84.4 million and a median of $78.6 million in 2024 frame the typical range for Total Non-Current Liabilities.
- Peak annual rise in Total Non-Current Liabilities reached 37.0% in 2022, while the deepest fall reached 41.73% in 2022.
- Tracing BFLY's Total Non-Current Liabilities over 5 years: stood at $91.6 million in 2022, then declined by 17.79% to $75.3 million in 2023, then grew by 4.36% to $78.6 million in 2024, then climbed by 17.32% to $92.2 million in 2025, then dropped by 6.51% to $86.2 million in 2026.
- Business Quant data shows BFLY's Total Non-Current Liabilities at $86.2 million in Q1 2026, $92.2 million in Q4 2025, and $76.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 176.64 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.78 Bn | 125.90 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 109.01 Bn | 99.79 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn | 2.64 Bn |
| 6 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn | 24.21 Bn |
| 7 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 3.53 Bn |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - | 3.57 Bn |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 9.85 Bn |
| 10 | Butterfly Network | 1.76 Bn | 1.62 Bn | 18.29 Mn | 86.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 86.23 Mn |
| Dec 31, 2025 | 92.23 Mn |
| Sep 30, 2025 | 76.65 Mn |
| Jun 30, 2025 | 70.99 Mn |
| Mar 31, 2025 | 69.83 Mn |
| Dec 31, 2024 | 78.61 Mn |
| Sep 30, 2024 | 72.51 Mn |
| Jun 30, 2024 | 78.37 Mn |
| Mar 31, 2024 | 72.04 Mn |
| Dec 31, 2023 | 75.33 Mn |
| Sep 30, 2023 | 75.36 Mn |
| Jun 30, 2023 | 85.52 Mn |
| Mar 31, 2023 | 79.96 Mn |
| Dec 31, 2022 | 91.62 Mn |
| Sep 30, 2022 | 99.00 Mn |
| Jun 30, 2022 | 109.25 Mn |
| Mar 31, 2022 | 121.93 Mn |
| Dec 31, 2021 | 98.05 Mn |
| Sep 30, 2021 | 72.26 Mn |
| Jun 30, 2021 | 182.63 Mn |